From academia, to startup, to big pharma, and back again?

被引：0

|

作者：

Landrum, Gregory ^{[1
]}

机构：

[1] NIBR, Basel, Switzerland

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2016年 / 251卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

27

引用

收藏

页数：1

相关论文

共 50 条

[1] Biotechs follow big pharma lead back into academia
Kling, Jim
[J]. NATURE BIOTECHNOLOGY, 2011, 29 (07) : 555 - 556
[2] Biotechs follow big pharma lead back into academia
Jim Kling
[J]. Nature Biotechnology, 2011, 29 : 555 - 556
[3] Correction: Corrigendum: Biotechs follow big pharma lead back into academia
Jim Kling
[J]. Nature Biotechnology, 2012, 30 (1) : 112 - 112
[4] Academia and Big Pharma United
Ljunggren, Hans-Gustaf
[J]. SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (217)
[5] From academia to industry ... and back again
Johnstone, Ashleigh
[J]. PSYCHOLOGIST, 2023, 36 : 86 - 89
[6] When big pharma courts academia
Paone, J
[J]. SCIENTIST, 2002, 16 (02): : 48 - 49
[7] Academia vs. big pharma: A comparison
Merrill, J. E.
[J]. JOURNAL OF NEUROCHEMISTRY, 2007, 102 : 96 - 96
[8] Revolving doors: from academia to industry and back again
Ross M Kedl
[J]. Nature Immunology, 2009, 10 : 227 - 229
[9] Revolving doors: from academia to industry and back again
Kedl, Ross M.
[J]. NATURE IMMUNOLOGY, 2009, 10 (03) : 227 - 229
[10] Biotechs follow big pharma lead back into academia (vol 29, pg 555, 2011)
Kling, Jim
[J]. NATURE BIOTECHNOLOGY, 2012, 30 (01)

← 1 2 3 4 5 →